Acute Pain Clinical Trials

Find Acute Pain Clinical Trials Near You

Repeated Bout Effect i Neuromuscular Diseases

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The repeated bout effect (RBE) refers to the adaptation whereby a single bout of eccentric exercise protects against muscle damage from subsequent eccentric bouts. This effect has been shown in many muscle groups using both serum biomarkers, muscle soreness and imaging techniques. Though the effect is well described in healthy, it has never been studied in patients with neuromuscular diseases (NMDs). In healthy, the RBE is only described using eccentric exercise, but unlike healthy persons, patients with NMDs can experience significant muscle damage with concentric exercise. This raises the question, if patients with NMDs could also show RBE when performing concentric exercise.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Age \> 18 years

• The ability to complete the exercise challenge

• No concurrent medical condition that could interfere with interpretation of the results

• Molecular diagnosis of the specific condition in specified patient groups or healthy control

• No active muscle injury on the test day (caused by recent exercise, seizures, trauma, etc.)

Locations
Other Locations
Denmark
Neuromuscular Research Unit, 3342
RECRUITING
Copenhagen
Contact Information
Primary
Mads Stemmerik, MD
mads.peter.godtfeldt.stemmerik@regionh.dk
+4535456126
Time Frame
Start Date: 2022-05-15
Estimated Completion Date: 2026-05-30
Participants
Target number of participants: 50
Treatments
Other: Exercise challenge
At baseline, subjects will perform the selected exercise challenge followed by blood samples collected at rest and 0, 2, 4, 24 hours and 4 days after end of exercise. Muscle soreness will be measured by asking the participant how sore their muscles in their thighs are on a visual-analog scale (1-10) at the same timepoints. After 4 weeks (+/- 3 days) of normal daily activity, the same test will be performed including blood samples.
Related Therapeutic Areas
Sponsors
Leads: Mads Peter Godtfeldt Stemmerik

This content was sourced from clinicaltrials.gov

Similar Clinical Trials